DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Bain VG, Kaita KD, Yoshida EM. et al.
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patients
J Hepatol 2006; 44: 671-678
We do not assume any responsibility for the contents of the web pages of other providers.